Riju Khetarpal, Life Sciences Managing Director, Box & Manu Vohra, Life Sciences Vice President, Content Management, USDM
To quickly bring life-saving therapies to market, the drug development process relies on secure collaboration across the extended enterprise. However, organizations find that today's legacy content management systems lead to silos between their regulated and unregulated content.
Read more >
With Box GxP Validation, pharma and life sciences companies can now validate Box so they can collaborate on, manage and distribute regulated clinical, lab and manufacturing content in Box. That means all of your content is standardized on a single content platform that meets regulatory and compliance standards, so you can eliminate inefficient silos, enable seamless collaboration and accelerate the validation process.
Join our webinar to learn how to:
- Leverage Box for your GxP content — such as collaborating with CROs — and consolidate expensive GxP-specific systems
- Cut validation time in half and save up to 75% in validation costs with always-on testing
- Meet CFR Part 11 requirements by integrating Box with e-signature providers, such as DocuSign
Hear about this new game-changing model for maintaining GxP compliance in the cloud with Riju Khetarpal, Life Sciences Managing Director at Box, and Manu Vohra, VP of Content Management at USDM Life Sciences.